Clinical Trial Update: The Duration Study [Phase 3]

View source ↗

Summary

The Duration Study, a Phase 3 trial sponsored by Johnson & Johnson Pharmaceutical Research & Development, has been terminated; results are not reported in this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 3 | Status: TERMINATED